• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.78% Nasdaq Down1.13%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    25.69 Down 1.50(5.52%) 4:00PM EDT
    |After Hours : 25.69 0.00 (0.00%) 4:32PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 130,902   148,199   113,708   99,851  
    Cost of Revenue26,559  24,900  22,867  18,605  
    Gross Profit 104,343   123,299   90,841   81,246  
    Operating Expenses
    Research Development43,988  43,356  31,229  30,636  
    Selling General and Administrative56,485  54,256  53,920  51,869  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 3,870   25,687   5,692   (1,259)
    Income from Continuing Operations
    Total Other Income/Expenses Net159  61  444  187  
    Earnings Before Interest And Taxes4,029  25,748  6,136  (1,072)
    Interest Expense3,374  4,037  4,010  4,051  
    Income Before Tax655  21,711  2,126  (5,123)
    Income Tax Expense(8,550)17,770  1,129  (2,038)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops9,205  3,941  997  (3,085)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 9,205   3,941   997   (3,085)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 9,205   3,941   997   (3,085)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.